Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Announces Senior Management Appointments in Commercialization and Manufacturing

Business Wire May 1, 2015

Second Sight to Discuss 2015 First Quarter Financial Results on May 13, 2015 Conference Call

Business Wire April 28, 2015

Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis

GlobeNewswire April 8, 2015

Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update

Business Wire March 11, 2015

Second Sight Announces Successful First Implants of the Argus® II Retinal Prosthesis System at Two New Centers in Italy

Business Wire March 5, 2015

Second Sight to Discuss Fourth Quarter and Year-End 2014 Financial Results on March 11, 2015 Conference Call

Business Wire February 27, 2015

Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System in France

Business Wire February 24, 2015

Second Sight to Present at the 27th Annual ROTH Conference on March 9, 2015

Business Wire February 23, 2015

Second Sight Receives Highest Priority Reimbursement for Argus II in Germany

Business Wire February 3, 2015

Health Canada Approves Second Sight's Argus II Retinal Prosthesis System for Treatment of Outer Retinal Degeneration

Business Wire January 12, 2015

Second Sight's Argus® II Retinal Prosthetic Implant to be Sold in Turkey

Business Wire December 17, 2014

Second Sight Announces Underwriter Exercises Over-Allotment Option

GlobeNewswire November 24, 2014

Second Sight Medical Products, Inc. (Nasdaq: EYES) to Ring The Nasdaq Stock Market Closing Bell in Celebration of IPO

GlobeNewswire November 19, 2014